ATB Therapeutics

Series-A
atbtherapeutics.com Biotech & Healthcare Aye, Belgium Founded 2017 11–50 employees
Total Funding $57M
Latest Round $57M Series-A
Last Announced Dec 2, 2024
Investors 10 Backers
Decision Makers 6 Available

About ATB Therapeutics

ATB Therapeutics is a biopharmaceutical company that provides novel therapeutic solutions and treatments for cancer patients.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Aye, Belgium
Year Founded 2017
Team Size 11–50 employees
Tracked Since Nov 8, 2026

Web & Domain Identity

Official Website atbtherapeutics.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Company Profile

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $57,000,000 · Series-A

    Backed by EQT Life Sciences

  2. Milestone

    Company founded

    Aye, Belgium

Investors & Backers

10
EQT Life Sciences
Lead
Financière Spin-Off Luxembourgeoise
Fournier-Majoie
MRL Ventures Fund
Sambrinvest
SFPIM
V-Bio Ventures
VIVES Funds
Walloon
WE International

Funding History

1 Round
Series-A equity · Dec 2, 2024

Round backers: EQT Life Sciences

Founders & Leadership

3

Bertrand Magy

Founder

Work email & phone locked Unlock →

Mark Throsby

Chief Executive Officer

Work email & phone locked Unlock →

Max Houry

Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts